throbber

`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`COALITION FOR AFFORDABLE DRUGS IV LLC
`
`Petitioner
`
`v.
`
`PHARMACYCLICS, INC.
`
`Patentee
`
`_____________________
`
`
`Case IPR2015-01076
`U.S. Patent No. 8,754,090
`TITLE: USE OF INHIBITORS OF BRUTON’S TYROSINE KINASE (BTK)
`Issue Date: June 17, 2014
`_____________________
`
`
`PETITIONER’S UPDATED APPENDIX OF EXHIBITS
`
`_____________________________________________________________
`
`
`
`
`
`1
`
`

`

`
`
`
`
`
`Description
`Exhibit
`Ex. 1001 U.S. Patent No. 8,754,090
`Ex. 1002 ClinicalTrials.gov Archive, Study of the Safety and
`Tolerability of PIC-32765 in Patients with Recurrent B Cell
`Lymphoma (February 23, 2009),
`https://clinicaltrials.gov/archive/NCT00849654/2009_02_23
`Ex. 1003 U.S. Patent App. Pub. No. 2008/0139582
`Ex. 1004 Press Release, Pharamacyclics, Pharmacyclics Initiates
`Phase I Clinical Trial of Novel Oral Btk Inhibitor for
`Refractory B-Cell Non-Hodgkin’s Lymphoma (April 13,
`2009)
`Ex. 1005 Zhengying Pan, et al., Discovery of Selective Irreversible
`Inhibitors for Bruton’s Tyrosine Kinase, 2 ChemMedChem
`58 (2007)
`Ex. 1006 Lee Honigberg et al., Targeting Btk in Lymphoma: PCI-
`32765 Inhibits Tumor Growth in Mouse Lymphoma Models
`and a Fluorescent Analog of PCI-32675 Is an Active-Site
`Probe That Enables Assessment of Btk Inhibition In Vivo,
`Blood (ASH Annual Meeting Abstracts) at 1592 (November
`2007)
`Ex. 1007 Christophe Le Tourneau et al., Dose Escalation Methods in
`Phase I Cancer Clinical Trials, 101 J. Nat’L Cancer Inst.
`708 (2009)
`Ex. 1008 Jonathan McConathy, Ph.D., & Michael J. Owens, Ph.D.,
`Stereochemistry in Drug Action, 5 Primary Care Companion
`J Clinical Psychiatry 70 (2003)
`Ex. 1009 Stefano A. Pileri & Brunangelo Falini, Mantle Cell
`Lymphoma, 94 Haematologica 1488 (2009)
`Ex. 1010 Agency For Toxic Substances and Disease Registry, Public
`Health Assessment Guidance Manual, (2005)
`Ex. 1011 MacPartlin et al., Bruton’s tyrosine kinase is not essential
`for Bcr-Abl-mediated transformation of lymphoid or
`myeloid cells, 22 Lekemia 1354 (2008)
`Ex. 1012 National Center for Biotechnology Information, PubChem
`Compound Database, CID=16126651, available at
`http://pubchem.ncbi.nlm.nih.gov/compound/16126651
`Ex. 1013 Elaine S. Jaffe, The 2008 WHO classification of
`lymphomas: implications for clinical practice and
`
`Filed
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`

`

`translational research, Hematology (2009)
`Ex. 1014 Original Claims, December 29, 2011, U.S. Patent App. No.
`13/340,522
`Ex. 1015 Examiner Initiated Interview Summary, December 23,
`2012, U.S. Patent App. No. 13/340,522
`Ex. 1016 Requirement for Restriction/Election, January 3, 2013, U.S.
`Patent App. No. 13/340,522
`Ex. 1017 Preliminary Amendment and Response to Restriction
`Requirement, February 4, 2013, U.S. Patent App. No.
`13/340,522
`Ex. 1018 Final Office Action, November 1, 2013, U.S. Patent App.
`No. 13/340,522
`Ex. 1019 Response to Final Office Action, December. 17, 2013, U.S.
`Patent App. No. 13/340,522
`Ex. 1020 Notice of Allowance, January 27, 2014, U.S. Patent App.
`No. 13/340,522
`Ex. 1021 Declaration by Djordje Atanackovic, M.D., Regarding U.S.
`Patent No. 8,754,090 Under 37 C.F.R. § 42.63(a)
`Ex. 1022 Curriculum Vitae of Djordje Atanackovic, M.D.
`Ex. 1023 R. Eric Davis, et al., Chronic Active B-Cell-Receptor
`Signalling in Diffuse Large B-Cell Lymphoma, Nature, Vol.
`463, Letters, pp. 88-92 (January 7, 2010)
`Ex. 1024 Declaration of Brent E. Routman in Support of Petitioner’s
`Motion for Admission Pro Hac Vice
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket